000 | 01950 a2200493 4500 | ||
---|---|---|---|
005 | 20250516013849.0 | ||
264 | 0 | _c20110324 | |
008 | 201103s 0 0 eng d | ||
022 | _a1083-351X | ||
024 | 7 |
_a10.1074/jbc.M110.146860 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMa, Chi | |
245 | 0 | 0 |
_aNeuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism. _h[electronic resource] |
260 |
_bThe Journal of biological chemistry _cFeb 2011 |
||
300 |
_a4819-28 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCerebellum _xcytology |
650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aHistone Deacetylases _xgenetics |
650 | 0 | 4 |
_aMAP Kinase Kinase Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aNeurons _xcytology |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aProtein Structure, Tertiary |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-jun _xbiosynthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
700 | 1 | _aD'Mello, Santosh R | |
773 | 0 |
_tThe Journal of biological chemistry _gvol. 286 _gno. 6 _gp. 4819-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M110.146860 _zAvailable from publisher's website |
999 |
_c20411043 _d20411043 |